NCT07104890

Brief Summary

This study evaluates the effect of the Enhanced Recovery After Surgery (ERAS) protocol on early postoperative recovery in women undergoing elective cesarean section. Eighty-four pregnant women, aged 18 years or older, at 37 weeks of gestation or beyond, without chronic medical conditions, and classified as ASA I-II, were enrolled. Participants were randomly assigned to either: ERAS group - received the ERAS protocol, including early oral intake, early mobilization, multimodal analgesia, and enhanced perioperative care Control group - received standard perioperative cesarean section care The study compared breastfeeding initiation time, gas passage, oral intake, mobilization time, and postoperative pain scores (VAS) between the two groups. The aim is to determine whether ERAS can accelerate recovery, reduce pain, and improve maternal comfort after elective cesarean delivery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2022

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
2.7 years until next milestone

First Submitted

Initial submission to the registry

July 29, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 5, 2025

Completed
Last Updated

August 5, 2025

Status Verified

July 1, 2025

Enrollment Period

1 month

First QC Date

July 29, 2025

Last Update Submit

July 29, 2025

Conditions

Keywords

Cesarean SectionElective CesareanEnhanced Recovery After SurgeryERASPostoperative RecoveryEarly MobilizationPostoperative PainMultimodal AnalgesiaObstetric Surgery

Outcome Measures

Primary Outcomes (1)

  • Time to First Mobilization After Cesarean Section

    Time from the end of elective cesarean section surgery to the patient's first ambulation, measured in hours. Early mobilization reflects enhanced postoperative recovery and is a key indicator of the ERAS protocol's effectiveness.

    Within 24 hours postoperatively

Secondary Outcomes (1)

  • Incidence of Postoperative Nausea and Vomiting

    Within 48 hours postoperatively

Study Arms (2)

ERAS Protocol Group

EXPERIMENTAL

Participants in this arm will receive the Enhanced Recovery After Surgery (ERAS) protocol during elective cesarean section. The ERAS protocol includes early oral intake, early mobilization, opioid-sparing multimodal analgesia, prophylactic antiemetics, early urinary catheter removal, and gum chewing to stimulate bowel function. Postoperative outcomes such as breastfeeding initiation, gas passage, oral intake time, mobilization, and VAS pain scores will be evaluated.

Behavioral: Enhanced Recovery After Surgery (ERAS) Protocol, which includes early oral intake, early mobilization, opioid-sparing multimodal analgesia, prophylactic antiemetics, early urinary catheter removal, an

Standard Care Group

ACTIVE COMPARATOR

Participants in this arm will receive standard perioperative cesarean care, which includes overnight fasting, delayed oral intake until gas passage, routine analgesia with paracetamol, NSAIDs and opioids as needed, later urinary catheter removal, and routine postoperative mobilization. Outcomes will be assessed similarly to the ERAS group.

Behavioral: Enhanced Recovery After Surgery (ERAS) Protocol, which includes early oral intake, early mobilization, opioid-sparing multimodal analgesia, prophylactic antiemetics, early urinary catheter removal, an

Interventions

The Enhanced Recovery After Surgery (ERAS) Protocol for elective cesarean section includes a multimodal perioperative care approach aimed at accelerating postoperative recovery. Key components are early oral intake, early mobilization, opioid-sparing multimodal analgesia, prophylactic antiemetics, early removal of the urinary catheter, and gum chewing to stimulate bowel function. This protocol is compared with Standard Perioperative Cesarean Care, which involves overnight fasting, delayed oral intake until bowel function returns, conventional analgesia, later mobilization, and routine catheter removal.

ERAS Protocol GroupStandard Care Group

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsOnly biologically female participants who are pregnant and scheduled for elective cesarean section are eligible for the study. Self-identified gender does not alter eligibility; participants must be biologically female.
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Pregnant women aged 18 years or older
  • Gestational age ≥37 weeks
  • Classified as ASA I or ASA II
  • Scheduled for elective cesarean section under spinal anesthesia
  • Able and willing to provide informed consent
  • No chronic systemic diseases

You may not qualify if:

  • Age \<18 years
  • Gestational age \<37 weeks
  • Emergency cesarean delivery
  • ASA III or higher
  • Presence of obstetric complications (e.g., preeclampsia, placenta previa, placental abruption, fetal distress)
  • Chronic comorbidities (e.g., diabetes, hypertension, cardiac or pulmonary disease)
  • Declines spinal anesthesia or unable to provide consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bartın City Hospital

Bartın, Turkey (Türkiye)

Location

Related Publications (2)

  • Khalafallah AM, Susic N, Shah KH, Knott MV, Berke CN, Gurses ME, Lu VM, Ivan ME, Komotar RJ, Shah AH. Evaluating safety and feasibility of same-day discharge after laser interstitial thermal therapy: a pilot study with a matched control group. J Neurooncol. 2025 Sep;174(2):341-347. doi: 10.1007/s11060-025-05055-4. Epub 2025 May 12.

    PMID: 40355785BACKGROUND
  • Zhang X, Ruan Y, Yuan Y, Li K. Is it necessary to maintain high adherence to enhanced recovery after surgery (ERAS) protocols?-A systematic review and meta-analysis. Curr Probl Surg. 2025 Aug;69:101814. doi: 10.1016/j.cpsurg.2025.101814. Epub 2025 May 30. No abstract available.

    PMID: 40716849BACKGROUND

MeSH Terms

Conditions

Pain, Postoperative

Interventions

Enhanced Recovery After SurgeryClinical ProtocolsEarly Ambulation

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Perioperative CareSurgical Procedures, OperativeTherapeuticsEpidemiologic Study CharacteristicsHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationRehabilitationAftercareContinuity of Patient CarePatient Care

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a single-center, prospective, randomized, parallel-group clinical trial. Participants were randomly assigned in a 1:1 ratio to either the ERAS protocol group or the standard care control group. Both groups were followed concurrently for postoperative recovery outcomes after elective cesarean section.
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR INVESTIGATOR
PI Title
M.D

Study Record Dates

First Submitted

July 29, 2025

First Posted

August 5, 2025

Study Start

October 1, 2022

Primary Completion

November 1, 2022

Study Completion

December 1, 2022

Last Updated

August 5, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared because the study is single-center, involves a small sample size of 84 participants, and contains sensitive obstetric patient information. Only de-identified summary data will be reported in publications.

Locations